Giles Davis - European Medicines Agency

Curriculum Vitae
PERSONAL INFORMATION
Giles Davis
WORK EXPERIENCE
December 2012–Present
Head of Pharmacovigilance Unit
VMD, (United Kingdom)
I lead the team responsible for processing and assessing reports of suspected adverse reactions
occurring in animals, humans or the environment, including residues violations and lack of efficacy to
veterinary medicines. We analyse all the reports received to help identify early new or emerging
issues
that may represent a change in the benefit:risk balance of veterinary medicinal products. The team is
also responsible for ensuring that pharmaceutical companies have adequate systems in place to
provide confidence that all reports received are recorded and transmitted appropriately.
A lot of this work is carried out in partnership with other Member States and Third Countries, so that
data can be shared and effective regulatory decisions can be agreed. Consequently I am the UK
member of the CVMP Pharmacovigilance Working Party and I also chair the VEDDRA sub group
which includes members from the USA and Canada and is working to harmonise the reporting
terminology used across the regions to facilitate the secure and accurate transmission of information
between governments around the world.
Another major role for the team is to promote the reporting of adverse events and to increase
transparency by putting more information on pharmacovigilance issues into the public domain.
November 2008–December 2012
Veterinary Assessor, Pharmaceuticals and Feed Additives Team
VMD, (United Kingdom)
My main role was assessing pharmaceutical applications with regard to efficacy and target animal
safety. This involved writing clear and concise assessment reports for the consideration of other
Member States and steering some extremely challenging negotiations where disagreements arose. I
also provided technical advice to companies on legal and scientific requirements for applications and
on conducting veterinary clinical trials in the UK as well as the classification of so-called ‘borderline
products’ where it is not clear whether a Marketing Authorisation is required. I also provided advice to
the Defra Antimicrobial Resistance Committee and have maintained my membership in my new role.
November 2008–Present
Saturday Vet
Pets First Ltd, (United Kingdom)
Alternate weekends at busy small animal clinic
October 2007–October 2008
Small Animal Vet
The Petcare Practice, (United Kingdom)
Sole charge, consulting and operating.
July 2003–October 2007
Veterinary Assistant in Mixed Practice
Bay Vets Ltd, (United Kingdom)
Regularly in charge of branch practice; heavily involved in management duties and day-to-day running
of small animal department.
EDUCATION AND TRAINING
8/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 1 / 2
Curriculum Vitae
April 2006–July 2007
Giles Davis
General Practitioner Certificate in Small Animal Practice
European School of Veterinary Postgraduate Studies, (United Kingdom)
Clinical topics in small animal veterinary medicine and surgery, management and finance skills.
October 1998–July 2003
Bachelor of Veterinary Science (Distinction)
University of Liverpool, (United Kingdom)
Preclinical (anatomy, biochemistry, physiology) and clinical (infectious diseases, parasitology,
pathology and pharmacology) topics related to veterinary medicine and surgery in all domestic
species, companion and farmed. Final year elective completed in farm animal medicine.
ADDITIONAL INFORMATION
Expertise
Publications
Clinical Trials, Small Animal Practice, Pharmacovigilance
Suspected Adverse Events 2012. Veterinary Record 2013 173: 573-576
G. Davis, A. Rooney, S. Cooles, et al.
Suspected Adverse Events 2013 Veterinary Record 2015 176: 11-14 G Davis, S.Cooles, N. Vasan
Projects
Memberships
Other Relevant Information
8/1/15
© European Union, 2002-2014 | http://europass.cedefop.europa.eu
Page 2 / 2